SC 13G/A | 2024-02-14 | Avoro Capital Advisors LLC | CymaBay Therapeutics, Inc. | 16,337,739 | 10.0% | EDGAR |
SC 13G/A | 2024-02-14 | PERCEPTIVE ADVISORS LLC | CymaBay Therapeutics, Inc. | 4,024,400 | 3.5% | EDGAR |
SC 13G/A | 2024-02-14 | COMMODORE CAPITAL LP | CymaBay Therapeutics, Inc. | 0 | 0.0% | EDGAR |
SC 13G | 2024-02-14 | JANUS HENDERSON GROUP PLC | CymaBay Therapeutics, Inc. | 6,103,797 | 5.4% | EDGAR |
SC 13G/A | 2024-02-13 | TCG Crossover GP I, LLC | CymaBay Therapeutics, Inc. | 0 | 0.0% | EDGAR |
SC 13G | 2024-02-13 | VANGUARD GROUP INC | CymaBay Therapeutics, Inc. | 6,306,149 | 5.6% | EDGAR |
SC 13G | 2024-01-25 | BlackRock Inc. | CymaBay Therapeutics, Inc. | 9,610,239 | 8.5% | EDGAR |
SC 13G | 2023-09-22 | RA CAPITAL MANAGEMENT, L.P. | CymaBay Therapeutics, Inc. | 6,940,000 | 6.2% | EDGAR |
SC 13G | 2023-09-11 | ADAGE CAPITAL PARTNERS GP, L.L.C. | CymaBay Therapeutics, Inc. | 3,685,625 | 3.8% | EDGAR |
SC 13G | 2023-03-10 | PERCEPTIVE ADVISORS LLC | CymaBay Therapeutics, Inc. | 5,278,962 | 5.6% | EDGAR |
SC 13G/A | 2023-02-14 | TCG Crossover GP I, LLC | CymaBay Therapeutics, Inc. | 5,905,400 | 6.2% | EDGAR |
SC 13G/A | 2023-02-14 | COMMODORE CAPITAL LP | CymaBay Therapeutics, Inc. | 5,738,500 | 6.8% | EDGAR |
SC 13G | 2022-07-08 | BlackRock Inc. | CymaBay Therapeutics, Inc. | 1,948,033 | 2.3% | EDGAR |
SC 13G/A | 2022-02-14 | COMMODORE CAPITAL LP | CymaBay Therapeutics, Inc. | 5,419,896 | 7.8% | EDGAR |
SC 13G/A | 2022-02-14 | Boxer Capital, LLC | CymaBay Therapeutics, Inc. | - | 0.0% | EDGAR |
SC 13G/A | 2022-02-11 | Avoro Capital Advisors LLC | CymaBay Therapeutics, Inc. | 12,800,000 | 14.7% | EDGAR |
SC 13G/A | 2022-02-01 | BlackRock Inc. | CymaBay Therapeutics, Inc. | 5,324,128 | 6.3% | EDGAR |
SC 13G | 2021-11-29 | TCG Crossover Management, LLC | CymaBay Therapeutics, Inc. | 5,905,400 | 7.0% | EDGAR |
SC 13G | 2021-07-12 | COMMODORE CAPITAL LP | CymaBay Therapeutics, Inc. | 3,529,465 | 5.1% | EDGAR |
SC 13G/A | 2021-02-16 | Foresite Capital Fund III, L.P. | CymaBay Therapeutics, Inc. | 1,641,804 | 2.4% | EDGAR |